Published in J Affect Disord on May 20, 2010
Zinc homeostasis and neurodegenerative disorders. Front Aging Neurosci (2013) 1.05
Effects of zinc supplementation in patients with major depression: a randomized clinical trial. Iran J Psychiatry (2013) 0.87
Low dietary or supplemental zinc is associated with depression symptoms among women, but not men, in a population-based epidemiological survey. J Affect Disord (2011) 0.86
Zinc deficiency is common in several psychiatric disorders. PLoS One (2013) 0.83
Is there a personalized medicine for mood disorders? Eur Arch Psychiatry Clin Neurosci (2010) 0.83
Zinc in the central nervous system: From molecules to behavior. Biofactors (2012) 0.81
Clinical implications of lipid peroxidation in acne vulgaris: old wine in new bottles. Lipids Health Dis (2010) 0.80
Biological consequences of zinc deficiency in the pathomechanisms of selected diseases. J Biol Inorg Chem (2014) 0.79
Concentration-Dependent Dual Mode of Zn Action at Serotonin 5-HT1A Receptors: In Vitro and In Vivo Studies. Mol Neurobiol (2015) 0.78
The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors. Crit Rev Food Sci Nutr (2016) 0.78
The severity of depressive symptoms vs. serum Mg and Zn levels in postmenopausal women. Biol Trace Elem Res (2013) 0.76
Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression. J Neural Transm (Vienna) (2016) 0.76
Serum 25-hydroxy vitamin D levels in patients with acne vulgaris and its association with disease severity. Clin Cases Miner Bone Metab (2015) 0.76
Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity. Neural Plast (2017) 0.75
Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims. J Psychiatr Res (2016) 0.75
The serum zinc concentration as a potential biological marker in patients with major depressive disorder. Metab Brain Dis (2016) 0.75
The Emerging Role for Zinc in Depression and Psychosis. Front Pharmacol (2017) 0.75
Peripheral zinc and neopterin concentrations are associated with mood severity in bipolar disorder in a gender-specific manner. Psychiatry Res (2017) 0.75
Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci (2009) 2.20
Investigational NMDA receptor modulators for depression. Expert Opin Investig Drugs (2011) 1.45
Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther (2007) 1.41
Mood disorders: regulation by metabotropic glutamate receptors. Biochem Pharmacol (2007) 1.22
Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor. Eur J Pharmacol (2003) 1.19
Laughing rats are optimistic. PLoS One (2012) 1.10
Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis. Arch Med Sci (2013) 1.09
Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol (2004) 1.09
Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor. CNS Drug Rev (2006) 1.08
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology (2012) 1.06
The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. Psychopharmacology (Berl) (2010) 1.05
Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord (2009) 1.05
Polish version of the Hypomania Checklist (HCL-32) scale: the results in treatment-resistant depression. Eur Arch Psychiatry Clin Neurosci (2009) 1.03
NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav (2007) 1.01
Lack of persistent effects of ketamine in rodent models of depression. Psychopharmacology (Berl) (2008) 1.01
Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants. Psychoneuroendocrinology (2007) 1.00
Trait pessimism predicts vulnerability to stress-induced anhedonia in rats. Neuropsychopharmacology (2013) 1.00
The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol (2013) 1.00
Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist. Pharmacol Biochem Behav (2005) 0.99
Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. Neuropharmacology (2004) 0.99
GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. Drugs Today (Barc) (2005) 0.99
A search for genes modulated by interleukin-6 alone or with interleukin-1beta in HepG2 cells using differential display analysis. Biochim Biophys Acta (2005) 0.98
Activation of the mGlu7 receptor elicits antidepressant-like effects in mice. Psychopharmacology (Berl) (2007) 0.97
The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials. J Affect Disord (2011) 0.96
Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull (2003) 0.96
The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.96
Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice. Pharmacol Biochem Behav (2002) 0.95
Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats. Eur Neuropsychopharmacol (2010) 0.94
Antidepressant-like activity of zinc: further behavioral and molecular evidence. J Neural Transm (Vienna) (2008) 0.94
Anxiolytic-like effects of PHCCC, an allosteric modulator of mGlu4 receptors, in rats. Eur J Pharmacol (2004) 0.93
Chronic psychosocial stress makes rats more 'pessimistic' in the ambiguous-cue interpretation paradigm. Behav Brain Res (2013) 0.93
mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants. Neuropharmacology (2012) 0.92
(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.92
Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep (2008) 0.92
"Broad spectrum" antidepressants: is more better for the treatment of depression? Life Sci (2003) 0.92
Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain. J Pharmacol Exp Ther (2007) 0.92
A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice. J Neural Transm (Vienna) (2011) 0.91
Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. PLoS One (2013) 0.91
Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems. Neuropharmacology (2010) 0.91
Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Neurochem Int (2009) 0.91
Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors. Eur J Med Chem (2012) 0.90
Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia. Psychopharmacology (Berl) (2011) 0.90
Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol Rep (2006) 0.90
Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology (Berl) (2002) 0.90
Zinc treatment induces cortical brain-derived neurotrophic factor gene expression. Eur J Pharmacol (2004) 0.89
The role of zinc in neurodegenerative inflammatory pathways in depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.89
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors. J Pharmacol Exp Ther (2006) 0.89
Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats. J Pharmacol Exp Ther (2010) 0.89
Simultaneous determination of buprenorphine and norbuprenorphine in serum by high-performance liquid chromatography-electrospray ionization-mass spectrometry. J Anal Toxicol (2005) 0.89
Immobility stress induces depression-like behavior in the forced swim test in mice: effect of magnesium and imipramine. Pharmacol Rep (2006) 0.88
Zinc and depression. An update. Pharmacol Rep (2005) 0.88
Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor. Neuropharmacology (2012) 0.88
On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039. Psychopharmacology (Berl) (2010) 0.88
Cooperative behavior of laboratory rats (Rattus norvegicus) in an instrumental task. J Comp Psychol (2011) 0.87
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysis. Arch Med Sci (2012) 0.87
The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling. Psychopharmacology (Berl) (2013) 0.86
Identification of novel serotonin transporter compounds by virtual screening. J Chem Inf Model (2014) 0.86
Effects of GABAB receptor ligands in rodent tests of anxiety-like behavior. Pharmacol Rep (2008) 0.86
Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test. Pharmacol Rep (2012) 0.85
NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice. Pharmacol Rep (2008) 0.85
Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav (2004) 0.85
Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity. Eur J Med Chem (2009) 0.85
Interaction of zinc with antidepressants in the forced swimming test in mice. Pol J Pharmacol (2003) 0.85
Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants. Pharmacol Rep (2012) 0.84
NMDA antagonists under investigation for the treatment of major depressive disorder. Expert Opin Investig Drugs (2014) 0.84
The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents. Br J Pharmacol (2013) 0.84
Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677. Cell Mol Neurobiol (2006) 0.84
Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice. Pharmacol Biochem Behav (2005) 0.84
Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims. Pol J Pharmacol (2003) 0.84
[The position of psychooncology in contemporary psychiatry]. Psychiatr Pol (2009) 0.84
GPR39 up-regulation after selective antidepressants. Neurochem Int (2013) 0.84
[Emotional disorders in patients with cerebellar damage--case studies]. Psychiatr Pol (2014) 0.84